-+ 0.00%
-+ 0.00%
-+ 0.00%

Tyra Biosciences prices USD 400 million stock, pre-funded warrant offering at USD 22.03 per share

PUBT·09/14/2026 10:45:37
Listen to the news
Tyra Biosciences prices USD 400 million stock, pre-funded warrant offering at USD 22.03 per share
  • Tyra Biosciences priced an underwritten offering expected to raise about USD 400 million in gross proceeds.
  • Deal includes 9,079,000 common shares at USD 22.03 per share.
  • Also issued pre-funded warrants for 9,078,529 shares at USD 22.029 each, with a USD 0.001 exercise price.
  • Closing is expected on Sept. 15, 2026, subject to customary conditions.
  • Net proceeds earmarked to advance dabogratinib “3x3” programs, fund R&D, working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tyra Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609140645PR_NEWS_USPR_____LA46725) on September 14, 2026, and is solely responsible for the information contained therein.